Skip to content
ClinicalSkin & HairTopical1–2x daily

Matrixyl (Palmitoyl Pentapeptide-4)

Pal-KTTKS · Matrixyl 3000

Lipidated procollagen-I fragment that feedback-stimulates fibroblast collagen/fibronectin synthesis. Reduces wrinkle depth in blinded trials.

§ 01   Overview

Overview

Lipidated procollagen-I fragment that feedback-stimulates fibroblast collagen/fibronectin synthesis. Reduces wrinkle depth in blinded trials.

Robinson 2005 topical RCT; Katayama 1993 collagen biology.

§ 02   Mechanism

Mechanism of action

Matrixyl is the procollagen-I C-terminus (KTTKS) lipidated with palmitic acid to cross the stratum corneum. It signals the fibroblast via the same feedback loop that procollagen fragments naturally use.

  • 01Reduced wrinkle depth in double-blind topical trial
  • 02Stimulates collagen I/IV, elastin, fibronectin

§ 03   Dosing

Dosing protocol

Standard Protocol

Dose Range
Formulation-dependent (typical 3–5%)
Route
Topical
Frequency
1–2x daily
Cycle
12+ weeks to observe

§ 04   Evidence

Evidence & research

Clinical

Robinson 2005 topical RCT; Katayama 1993 collagen biology.

FDA Status

Cosmetic ingredient; not a drug.

§ 06   News

In the news

8 articles from the last 12 months · updates hourly

§ 07   Sourcing

Sourcing & supply

Regulatory status

Available as dietary supplement

Sold as a dietary supplement. Quality varies widely by brand; prefer GRAS-designated products with third-party testing (e.g. Mitopure for Urolithin A).

No suppliers in our directory currently stock this compound. For investigational or research-only compounds, legitimate channels may not exist outside clinical trials.

Browse full supplier directory

§ 09   Safety

Safety & side effects

Side effects

  • 01Rare contact irritation

Contraindications

None specified.

§ 10   Questions

Matrixyl (Palmitoyl Pentapeptide-4) FAQ

What is Matrixyl (Palmitoyl Pentapeptide-4)?
Lipidated procollagen-I fragment that feedback-stimulates fibroblast collagen/fibronectin synthesis. Reduces wrinkle depth in blinded trials. Matrixyl is the procollagen-I C-terminus (KTTKS) lipidated with palmitic acid to cross the stratum corneum. It signals the fibroblast via the same feedback loop that procollagen fragments naturally use.
What is Matrixyl (Palmitoyl Pentapeptide-4) used for?
Reported uses include reduced wrinkle depth in double-blind topical trial and stimulates collagen i/iv, elastin, fibronectin. Evidence strength is rated Clinical — see the evidence section for detail.
How is Matrixyl (Palmitoyl Pentapeptide-4) dosed?
Commonly referenced dosing is Formulation-dependent ( 3–5%), typically 1–2x daily, administered Topical. This is educational reference only; consult a licensed clinician before use.
What are the side effects of Matrixyl (Palmitoyl Pentapeptide-4)?
Commonly reported side effects include rare contact irritation. This list is not exhaustive.
Is Matrixyl (Palmitoyl Pentapeptide-4) legal?
Sold as a dietary supplement. Quality varies widely by brand; prefer GRAS-designated products with third-party testing (e.g. Mitopure for Urolithin A). FDA status: Cosmetic ingredient; not a drug..

§ 11   References

Selected references

  1. 01

    Robinson — topical RCT

    PMID: 18492178

  2. 02

    Katayama — KTTKS biology

    PMID: 8226859

This site is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.